This lecture by Professor Adeera Levin emphasizes the urgent need for early detection and intervention in chronic kidney disease (CKD), noting that even mild cases require prompt action, including consideration of sodium-glucose co-transporter 2 (SGLT2) inhibitors like empagliflozin, which have demonstrated the potential to significantly delay kidney replacement therapy by over 26 years.

This lecture by Professor Christoph Wanner emphasizes the importance of early diagnosis and treatment of chronic kidney disease (CKD), particularly in patients with cardiovascular comorbidities, advocating for

This lecture by Professor Christoph Wanner emphasizes the importance of early diagnosis and treatment of chronic kidney disease (CKD), particularly in patients with cardiovascular comorbidities, advocating for comprehensive screening methods and timely treatment to improve patient outcomes.